Neogenomics (NEO) Assets Average (2011 - 2026)

Neogenomics (NEO) has 16 years of Assets Average data on file, last reported at $1.3 billion in Q2 2026.

• Quarterly Assets Average fell 9.9% year-over-year to $1.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 billion (down 9.9% YoY) and the FY2025 annual result came in at $1.5 billion, down 9.68% from the prior year.
• Assets Average held at $1.3 billion in Q2 2026, from $1.4 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.8 billion in Q1 2022 to a low of $1.3 billion in Q2 2026.
• A 5-year average of $1.6 billion and a median of $1.7 billion in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average surged 142.74% — and 2025, when it retreated 16.61%.
• Tracing NEO's Assets Average over 5 years: stood at $1.7 billion in 2022, then declined by 3.89% to $1.7 billion in 2023, then retreated by 2.39% to $1.6 billion in 2024, then dropped by 16.61% to $1.4 billion in 2025, then retreated by 1.31% to $1.3 billion in 2026.
• The last three Assets Average figures came in at $1.3 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.